Supplementation of triple viable probiotics combined with dietary intervention is associated with gut microbial improvement in humans on a high‑fat diet
- Authors:
- Leimin Qian
- Renyuan Gao
- Jianming Huang
- Huanlong Qin
-
Affiliations: Department of Gastrointestinal Surgery, Jiangyin People's Hospital, Jiangyin, Jiangsu 214400, P.R. China, Department of General Surgery, The Tenth People's Hospital Affiliated to Tongji University, Shanghai 200072, P.R. China - Published online on: July 23, 2019 https://doi.org/10.3892/etm.2019.7801
- Pages: 2262-2270
This article is mentioned in:
Abstract
 |
 |
 |
 |
|
Zoetendal EG, Rajilic-Stojanovic M and de Vos WM: High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut. 57:1605–1615. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Zoetendal EG, Raes J, van den Bogert B, Arumugam M, Booijink CC, Troost FJ, Bork P, Wels M, de Vos WM and Kleerebezem M: The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J. 6:1415–1426. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Hooper LV, Midtvedt T and Gordon JI: How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr. 22:283–307. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Backhed F, Ley RE, Sonnenburg JL, Peterson DA and Gordon JI: Host-bacterial mutualism in the human intestine. Science. 307:1915–1920. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al: A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 464:59–65. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lin CS, Chang CJ, Lu CC, Martel J, Ojcius DM, Ko YF, Young JD and Lai HC: Impact of the gut microbiota, prebiotics, and probiotics on human health and disease. Biomed J. 37:259–268. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Brown K, DeCoffe D, Molcan E and Gibson DL: Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients. 4:1095–1119. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Abu-Shanab A and Quigley EM: The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 7:691–701. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Chiu CC, Ching YH, Li YP, Liu JY, Huang YT, Huang YW, Yang SS, Huang WC and Chuang HL: Nonalcoholic fatty liver disease is exacerbated in High-Fat Diet-Fed gnotobiotic mice by colonization with the Gut Microbiota from patients with nonalcoholic steatohepatitis. Nutrients. 9:E12202017. View Article : Google Scholar : PubMed/NCBI | |
|
Federico A, Dallio M, Caprio GG, Ormando VM and Loguercio C: Gut microbiota and the liver. Minerva Gastroenterol Dietol. 63:385–398. 2017.PubMed/NCBI | |
|
Budden KF, Gellatly SL, Wood DL, Cooper MA, Morrison M, Hugenholtz P and Hansbro PM: Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol. 15:55–63. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Bercik P: The microbiota-gut-brain axis: Learning from intestinal bacteria? Gut. 60:288–289. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Collins SM and Bercik P: Gut microbiota: Intestinal bacteria influence brain activity in healthy humans. Nat Rev Gastroenterol Hepatol. 10:326–327. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Bienenstock J, Kunze W and Forsythe P: Microbiota and the gut-brain axis. Nutr Rev. 73 (Suppl 1):S28–S31. 2015. View Article : Google Scholar | |
|
Dinan TG and Cryan JF: Gut-brain axis in 2016: Brain-gut-microbiota axis-mood, metabolism and behaviour. Nat Rev Gastroenterol Hepatol. 14:69–70. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, et al: Enterotypes of the human gut microbiome. Nature. 473:174–180. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, et al: Linking long-term dietary patterns with gut microbial enterotypes. Science. 334:105–108. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Bushman FD, Lewis JD and Wu GD: Diet, gut enterotypes and health: Is there a link? Nestle Nutr Inst Workshop Ser. 77:65–73. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kim KA, Gu W, Lee IA, Joh EH and Kim DH: High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One. 7:e477132012. View Article : Google Scholar : PubMed/NCBI | |
|
David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, et al: Diet rapidly and reproducibly alters the human gut microbiome. Nature. 505:559–563. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Schulz MD, Atay C, Heringer J, Romrig FK, Schwitalla S, Aydin B, Ziegler PK, Varga J, Reindl W, Pommerenke C, et al: High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature. 514:508–512. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ou JH, Ridlon JM, DeLany JP, Vipperla K, Newton K and O'Keefe SJ: Obesity and colon cancer risk: Is it the Fat? Gastroenterology. 142:S3132012. View Article : Google Scholar | |
|
Gerritsen J, Smidt H, Rijkers GT and de Vos WM: Intestinal microbiota in human health and disease: The impact of probiotics. Genes Nutr. 6:209–240. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Hu X, Wang T, Li W, Jin F and Wang L: Effects of NS Lactobacillus strains on lipid metabolism of rats fed a high-cholesterol diet. Lipids Health Dis. 12:672013. View Article : Google Scholar : PubMed/NCBI | |
|
Liboredo JC, Anastacio LR, Peluzio Mdo C, Valente FX, Penido LC, Nicoli JR and Correia MI: Effect of probiotics on the development of dimethylhydrazine-induced preneoplastic lesions in the mice colon. Acta Cir Bras. 28:367–372. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Bertkova I, Hijova E, Chmelarova A, Mojzisova G, Petrasova D, Strojny L, Bomba A and Zitnan R: The effect of probiotic microorganisms and bioactive compounds on chemically induced carcinogenesis in rats. Neoplasma. 57:422–428. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Wang W, Shi LP, Shi L and Xu L: Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease. Zhonghua Nei Ke Za Zhi. 57:101–106. 2018.(In Chinese). PubMed/NCBI | |
|
Fan YJ, Chen SJ, Yu YC, Si JM and Liu B: A probiotic treatment containing Lactobacillus, bifidobacterium and enterococcus improves IBS symptoms in an open label trial. J Zhejiang Univ Sci B. 7:987–991. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Y, Xia Y, Chen H, Hong L, Feng J, Yang J, Yang Z, Shi C, Wu W, Gao R, et al: The effect of perioperative probiotics treatment for colorectal cancer: Short-term outcomes of a randomized controlled trial. Oncotarget. 7:8432–8440. 2016.PubMed/NCBI | |
|
Liang S, Xu L, Zhang D and Wu Z: Effect of probiotics on small intestinal bacterial overgrowth in patients with gastric and colorectal cancer. Turk J Gastroenterol. 27:227–232. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Knights D, Ward TL, McKinlay CE, Miller H, Gonzalez A, McDonald D and Knight R: Rethinking ‘enterotypes’. Cell Host Microbe. 16:433–437. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Xia F, Chen J, Fung WK and Li H: A logistic normal multinomial regression model for microbiome compositional data analysis. Biometrics. 69:1053–1063. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Qian L, Gao R, Hong L, Pan C, Li H, Huang J and Qin H: Association analysis of dietary habits with gut microbiota of a native Chinese community. Exp Ther Med. 16:856–866. 2018.PubMed/NCBI | |
|
Wan Y, Wang F, Yuan J, Li J, Jiang D, Zhang J, Huang T, Zheng J, Mann J and Li D: Effects of macronutrient distribution on weight and related cardiometabolic profile in healthy non-obese Chinese: A 6-month, randomized controlled-feeding trial. Ebiomedicine. 22:200–207. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Li W and Godzik A: Cd-hit: A fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics. 22:1658–1659. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Deng W, Wang Y, Liu Z, Cheng H and Xue Y: HemI: A toolkit for illustrating heatmaps. PLoS One. 9:e1119882014. View Article : Google Scholar : PubMed/NCBI | |
|
Weichselbaum E: Potential benefits of probiotics-main findings of an in-depth review. Br J Community Nurs. 15(110): 112–114. 2010. | |
|
Iannitti T and Palmieri B: Therapeutical use of probiotic formulations in clinical practice. Clin Nutr. 29:701–725. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Gareau MG, Sherman PM and Walker WA: Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol. 7:503–514. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Chan YK, Brar MS, Kirjavainen PV, Chen Y, Peng J, Li D, Leung FC and El-Nezami H: High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size, plasma A-FABP and cholesterol: A pilot study of high fat diet and its intervention with Lactobacillus rhamnosus GG (LGG) or telmisartan in ApoE(−/-) mice. BMC Microbiol. 16:2642016. View Article : Google Scholar : PubMed/NCBI | |
|
Kato-Kataoka A, Nishida K, Takada M, Kawai M, Kikuchi-Hayakawa H, Suda K, Ishikawa H, Gondo Y, Shimizu K, Matsuki T, et al: Fermented milk containing Lactobacillus casei strain shirota preserves the diversity of the gut microbiota and relieves abdominal dysfunction in healthy medical students exposed to academic stress. Appl Environ Microbiol. 82:3649–3658. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Lisko DJ, Johnston GP and Johnston CG: Effects of dietary yogurt on the healthy human gastrointestinal (GI) microbiome. Microorganisms. 5:E62017. View Article : Google Scholar : PubMed/NCBI | |
|
Kristensen NB, Bryrup T, Allin KH, Nielsen T, Hansen TH and Pedersen O: Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: A systematic review of randomized controlled trials. Genome Med. 8:522016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J, Wang L, Guo Z, Sun Z, Gesudu Q, Kwok L, Menghebilige and Zhang H: 454 pyrosequencing reveals changes in the faecal microbiota of adults consuming Lactobacillus casei Zhang. FEMS Microbiol Ecol. 88:612–622. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Park DY, Ahn YT, Park SH, Huh CS, Yoo SR, Yu R, Sung MK, McGregor RA and Choi MS: Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS One. 8:e594702013. View Article : Google Scholar : PubMed/NCBI | |
|
Backhed F, Fraser CM, Ringel Y, Sanders ME, Sartor RB, Sherman PM, Versalovic J, Young V and Finlay BB: Defining a healthy human gut microbiome: Current concepts, future directions, and clinical applications. Cell Host Microbe. 12:611–622. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Hanifi A, Culpepper T, Mai V, Anand A, Ford AL, Ukhanova M, Christman M, Tompkins TA and Dahl WJ: Evaluation of bacillus subtilis R0179 on gastrointestinal viability and general wellness: A randomised, double-blind, placebo-controlled trial in healthy adults. Benef Microbes. 6:19–27. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, Chen YY, Knight R, Ahima RS, Bushman F and Wu GD: High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology. 137:1716–1724.e1-2. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Heinsen FA, Fangmann D, Muller N, Schulte DM, Ruehlemann MC, Turk K, Settgast U, Lieb W, Baines JF, Schreiber S, et al: Beneficial effects of a dietary weight loss intervention on human gut microbiome diversity and metabolism are not sustained during weight maintenance. Obes Facts. 9:379–391. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Bell DS: Changes seen in gut bacteria content and distribution with obesity: Causation or association? Postgrad Med. 127:863–868. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Shang Y, Khafipour E, Derakhshani H, Sarna LK, Woo CW, Siow YL and O K: Short term high fat diet induces Obesity-Enhancing changes in mouse gut microbiota that are partially reversed by cessation of the high fat diet. Lipids. 52:499–511. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Schwiertz A, Taras D, Schafer K, Beijer S, Bos NA, Donus C and Hardt PD: Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 18:190–195. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Duncan SH, Lobley GE, Holtrop G, Ince J, Johnstone AM, Louis P and Flint HJ: Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond). 32:1720–1724. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Human Microbiome Project Consortium: Structure, function and diversity of the healthy human microbiome. Nature. 486:207–214. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J, Guo Z, Xue Z, Sun Z, Zhang M, Wang L, Wang G, Wang F, Xu J, Cao H, et al: A phylo-functional core of gut microbiota in healthy young Chinese cohorts across lifestyles, geography and ethnicities. ISME J. 9:1979–1990. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Mariat D, Firmesse O, Levenez F, Guimaraes V, Sokol H, Dore J, Corthier G and Furet JP: The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 9:1232009. View Article : Google Scholar : PubMed/NCBI | |
|
Kang C, Wang B, Kaliannan K, Wang X, Lang H, Hui S, Huang L, Zhang Y, Zhou M, Chen M and Mi M: Gut microbiota mediates the protective effects of dietary capsaicin against chronic low-grade inflammation and associated obesity induced by high-fat diet. MBio. 8:e00470–e00417. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ferrario C, Taverniti V, Milani C, Fiore W, Laureati M, De Noni I, Stuknyte M, Chouaia B, Riso P and Guglielmetti S: Modulation of fecal clostridiales bacteria and butyrate by probiotic intervention with Lactobacillus paracasei DG varies among healthy adults. J Nutr. 144:1787–1796. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Song JJ, Tian WJ, Kwok LY, Wang YL, Shang YN, Menghe B and Wang JG: Effects of microencapsulated Lactobacillus plantarum LIP-1 on the gut microbiota of hyperlipidaemic rats. Brit J Nutr. 118:481–492. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Eeckhaut V, Machiels K, Perrier C, Romero C, Maes S, Flahou B, Steppe M, Haesebrouck F, Sas B, Ducatelle R, et al: Butyricicoccus pullicaecorum in inflammatory bowel disease. Gut. 62:1745–1752. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Devriese S, Eeckhaut V, Geirnaert A, Van den Bossche L, Hindryckx P, Van de Wiele T, Van Immerseel F, Ducatelle R, De Vos M and Laukens D: Reduced Mucosa-associated butyricicoccus activity in patients with ulcerative colitis correlates with aberrant claudin-1 expression. J Crohns Colitis. 11:229–236. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, Brown D, Stares MD, Scott P, Bergerat A, et al: Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 5:220–230. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
An C, Kuda T, Yazaki T, Takahashi H and Kimura B: Caecal fermentation, putrefaction and microbiotas in rats fed milk casein, soy protein or fish meal. Appl Microbiol Biotechnol. 98:2779–2787. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Park S, Ji Y, Jung HY, Park H, Kang J, Choi SH, Shin H, Hyun CK, Kim KT and Holzapfel WH: Lactobacillus plantarum HAC01 regulates gut microbiota and adipose tissue accumulation in a diet-induced obesity murine model. Appl Microbiol Biotechnol. 101:1605–1614. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Saitoh S, Noda S, Aiba Y, Takagi A, Sakamoto M, Benno Y and Koga Y: Bacteroides ovatus as the predominant commensal intestinal microbe causing a systemic antibody response in inflammatory bowel disease. Clin Diagn Lab Immunol. 9:54–59. 2002.PubMed/NCBI | |
|
Dicksved J, Halfvarson J, Rosenquist M, Jarnerot G, Tysk C, Apajalahti J, Engstrand L and Jansson JK: Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J. 2:716–727. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
El Hage R, Hernandez-Sanabria E and Van de Wiele T: Emerging trends in ‘Smart Probiotics’: Functional consideration for the development of novel health and industrial applications. Front Microbiol. 8:18892017. View Article : Google Scholar : PubMed/NCBI | |
|
Winter J, Moore LH, Dowell VR Jr and Bokkenheuser VD: C-ring cleavage of flavonoids by human intestinal bacteria. Appl Environ Microbiol. 55:1203–1208. 1989.PubMed/NCBI | |
|
Kasai C, Sugimoto K, Moritani I, Tanaka J, Oya Y, Inoue H, Tameda M, Shiraki K, Ito M, Takei Y and Takase K: Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing. BMC Gastroenterol. 15:1002015. View Article : Google Scholar : PubMed/NCBI | |
|
Fang D, Shi D, Lv L, Gu S, Wu W, Chen Y, Chen Y, Guo J, Li A, Xinjun Hu, et al: Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota. Sci Rep. 7:87702017. View Article : Google Scholar : PubMed/NCBI | |
|
Toscano M, De Grandi R, Miniello VL, Mattina R and Drago L: Ability of Lactobacillus kefiri LKF01 (DSM32079) to colonize the intestinal environment and modify the gut microbiota composition of healthy individuals. Dig Liver Dis. 49:261–267. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Jimenez MB: Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last? Rev Esp Enferm Dig. 101:553–564. 2009.PubMed/NCBI | |
|
van den Bogert B, Meijerink M, Zoetendal EG, Wells JM and Kleerebezem M: Immunomodulatory properties of Streptococcus and Veillonella isolates from the human small intestine microbiota. PLoS One. 9:e1142772014. View Article : Google Scholar : PubMed/NCBI | |
|
Garrido D, Suau A, Pochart P, Cruchet S and Gotteland M: Modulation of the fecal microbiota by the intake of a Lactobacillus johnsonii La1-containing product in human volunteers. FEMS Microbiology Letters. 248:249–256. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu Q, Jin Z, Wu W, Gao R, Guo B, Gao Z, Yang Y and Qin H: Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer. PLoS One. 9:e908492014. View Article : Google Scholar : PubMed/NCBI | |
|
Hibberd AA, Lyra A, Ouwehand AC, Rolny P, Lindegren H, Cedgard L and Wettergren Y: Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention. BMJ Open Gastroenterol. 4:e0001452017. View Article : Google Scholar : PubMed/NCBI | |
|
Wong SH, Kwong TNY, Chow TC, Luk AKC, Dai RZW, Nakatsu G, Lam TYT, Zhang L, Wu JCY, Chan FKL, et al: Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia. Gut. 66:1441–1418. 2017. View Article : Google Scholar : PubMed/NCBI |
